Denali Therapeutics Inc.DNLINASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-2.89
Operating CF/Share$-2.31
Free CF/Share$-2.38
Cash/Share$4.92
Book Value/Share$5.37
Tangible Book/Share$5.37
Equity/Share$5.37
Interest Debt/Share$0.26
CapEx/Share$0.08
Dividend/Share$0.00
Valuation
Market Cap$3.52B
Enterprise Value$3.47B
P/E Ratio-7.79P/S Ratio0.00P/OCF Ratio-9.76
P/FCF Ratio-8.56
P/B Ratio4.19P/TB Ratio4.19
EV/Sales0.00EV/EBITDA-6.50
Graham Valuation
Graham Number--
Graham Net-Net$4.18
Profitability
Earnings Yield-12.84%FCF Yield-11.68%ROE-46.33%ROIC-56.21%Return on Tangible Assets-47.25%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-3.29%
CapEx/Revenue0.00%
CapEx/Depreciation1.18
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.05Debt/Assets0.04Debt/Market Cap0.01
Net Debt/EBITDA0.09
Current Ratio9.79Interest Coverage0.00xIncome Quality0.80Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding0 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$926.20M
Working Capital$792.45M
Invested Capital$915.67M
Intangibles/Assets0.00%